Key result
Intraperitoneal injection of OK-432 successfully resolved intractable ascites in a 20-year-old woman with epithelioid haemangioendothelioma, rendering her symptom-free.
Why the study?
Does intraperitoneal OK-432 injection improve intractable ascites in a patient with epithelioid haemangioendothelioma?
Case Report (n=1)
Does intraperitoneal OK-432 injection improve intractable ascites in a patient with epithelioid haemangioendothelioma?
Intraperitoneal OK-432 injection may serve as an effective palliative treatment for intractable ascites secondary to epithelioid haemangioendothelioma.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for palliative ascites control in this rare tumor; prospective studies needed before any clinical adoption.
Wei et al. (1997) conducted a case report in Epithelioid haemangioendothelioma with intractable ascites (n=1). Intraperitoneal injection of OK-432 was evaluated on Resolution of ascites and symptom relief. Intraperitoneal injection of OK-432 successfully resolved intractable ascites in a 20-year-old woman with epithelioid haemangioendothelioma, rendering her symptom-free.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: